Leukemia Research
Volume 25, Issue 9 , Pages 783-791 , 1 September 2001

Poor prognosis acute myelogenous leukemia: 3—biological and molecular biological changes during remission induction therapy

Received 10 April 2000 ,Accepted 21 January 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(01)00032-7

Leukemia Research
Volume 25, Issue 9 , Pages 783-791 , 1 September 2001